×
The Investor Relations website contains information about Jazz Pharmaceuticals plc's business for stockholders, potential investors, and financial analysts.
GW Pharmaceuticals is a cutting-edge UK-based biopharmaceutical company that over the last 20 years has established a world-leading position in cannabinoid ...
Earnings materials are available publicly on the Investor Relations page of GW's website at http://www.gwpharm.com. Questions may be directed to Investor ...
People also ask
INVESTOR RELATIONS. > Investor Relations > Information Disclosure. Information Disclosure · Corporate Governance · Stock Information · Contact us · Grand Pharma ...
Feb 3, 2021 · Investor Contacts. Andrea N. Flynn, Ph.D. Vice President, Head, Investor Relations. investorinfo@jazzpharma.com. Ireland: +353 1 634 3211
Missing: gwph | Show results with:gwph
The Investor Relations website contains information about YS Biopharma Co., Ltd.'s business for stockholders, potential investors, and financial analysts.
Sep 16, 2019 · Seeking Alpha's transcripts team is responsible for the development of all of our transcript-related projects.
$3.02
Investor Contacts. Company. Narayan Prabhu, CFO Reviva Pharmaceuticals. Phone: 408.501.8881. Email: info.rp@revivapharma.com. Investor Relations. Ben Shamsian
Missing: gwph | Show results with:gwph
May 5, 2021 · Jazz Pharmaceuticals (Nasdaq: JAZZ) today announced the completion of its acquisition of · GW Pharmaceuticals plc (Nasdaq: GWPH) ("GW"), a leader ...
Because of these factors, our financial results in one or more future quarters may fail to meet the expectations of securities analysts or investors, which ...